Hi coldnewfie.

You wrote " I am starting to think RVX is on it's way to not needing a new listing and will not be around by the end of the year due to a deal."

The more I think about this the more sense it makes to me. rvx-208 going into phase 3 and in a sense moving closer to market. The Hepalink deal. Don has said he is in discussions with multiple companies and for every distribution/licensing deal he sets up the more value he adds to RVX in terms of purchase price. Don is in the drug development business and rvx-208 is developed. But at Zenith, as Don said in the webcast, they have many platforms in development. So it makes sense to get the first born out the door and start with the new ones.

I hope you are right!

GLTA IMHO DYODD

Cheers

Toinv